Sort
48,018 grants matching “immunotherapy”
Allergen T cell epitopes and phenotypes in peanut allergy and immunotherapy
$1,016,640William W. Kwok · Benaroya Research Inst At Virginia Mason · U19 · FY2021 · AI
Allergen T cell epitopes and phenotypes in peanut allergy and immunotherapy
$1,016,640William W. Kwok · Benaroya Research Inst At Virginia Mason · U19 · FY2018 · AI
Allergen T cell epitopes and phenotypes in peanut allergy and immunotherapy
$1,016,640William W. Kwok · Benaroya Research Inst At Virginia Mason · U19 · FY2022 · AI
Stem Cell Biology, Cancer Stem Cell Biology, and Cancer Immunotherapy
$1,016,525Irving Lerner Weissman · Stanford University · R35 · FY2021 · CA
Modeling the ecology of tissue-resident T cells
$1,016,413Andrew Yates · Columbia University Health Sciences · U01 · FY2024 · AI
Integrating systems immunology with immunometabolism and cancer immunity
$1,016,190Hongbo Chi · St. Jude Children'S Research Hospital · R35 · FY2024 · CA
Targeting intratumor heterogeneity in breast cancer
$1,015,451Kornelia Polyak · Dana-Farber Cancer Inst · R35 · FY2023 · CA
Mechanism of action and therapeutic utility of immunostimulatory CpG oligonucleo
$1,015,446Dennis Klinman · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Spatial functional genomics to identify regulators of the tumor microenvironment and cancer immunity
$1,015,368Brian D Brown · Icahn School Of Medicine At Mount Sinai · U01 · FY2025 · CA
Mechanisms and Optimal Combinations of Cisplatin Chemotherapy for Head and Neck Squamous Cell Carcinoma
$1,015,160Nicole Schmitt · National Institute On Deafness And Other Communication Disorders · ZIA · FY2018 · DC
Immunotherapeutics Against Arenaviruses
$1,015,070Robert F Garry · Scripps Research Institute, The · U19 · FY2014 · AI
SPORE in Pancreatic Cancer
$1,015,068University Of Alabama At Birmingham · P20 · FY2005 · CA
A Rational Systematic Approach to Find Combinations of Pharmacologic and Immune Therapies that Target Identifiable Oncogenic States
$1,014,721Pablo Tamayo · University Of California, San Diego · U01 · FY2018 · CA
The role of the intestinal microbiome in cancer immunotherapy
$1,014,601Marcel R M Van Den Brink · Beckman Research Institute/City Of Hope · R35 · FY2024 · CA
Tissue Processing-Sequencing Facility
$1,014,563Cathy D Vocke · Division Of Basic Sciences - Nci · ZIC · FY2020 · CA
Reprogramming of T cells for the Treatment of Melanoma
$1,014,415Kai W Wucherpfennig · Dana-Farber Cancer Inst · R01 · FY2012 · CA
TRANSPLANT TOLERANCE
$1,014,106Emory University · U19 · FY2003 · AI
SPORE in Gastrointestinal Cancer
$1,013,333Michael A Hollingsworth · University Of Nebraska Medical Center · P50 · FY2011 · CA
Induction of an Antitumor Immune Response in Patients with Melanoma
$1,013,259Patrick Hwu · University Of Tx Md Anderson Can Ctr · P50 · FY2010 · CA
Molecular Allergy
$1,012,926Geoffrey Mueller · National Institute Of Environmental Health Sciences · ZIA · FY2025 · ES
Targeting Pediatric Cancer Vulnerabilities
$1,012,869Kimberly Stegmaier · Dana-Farber Cancer Inst · R35 · FY2024 · CA
Targeting Epigenetic Circuits in B-Cell Lymphomas
$1,012,843Ari M. Melnick · Weill Medical Coll Of Cornell Univ · R35 · FY2021 · CA
Human EGFRvIII-specific BiTE for the treatment of Glioblastoma
$1,012,736John H Sampson · Duke University · U01 · FY2018 · NS
Dissecting Pediatric Brain Tumor Microenvironment to Improve Treatment
$1,012,680Rakesh K. Jain · Massachusetts General Hospital · R35 · FY2019 · CA
Phase I therapeutic testing of viral-vectored vaccines that shift CD8+ T cell immunodominance to conserved regions of HIV-1
$1,012,608Nilu Goonetilleke · Univ Of North Carolina Chapel Hill · U01 · FY2017 · AI